CORNERSTONE THERAPEUTICS INC Research and Development Expense
CORNERSTONE THERAPEUTICS INC reported Research and Development Expense of $594.00 thousand for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2013-11-07
- CORNERSTONE THERAPEUTICS INC research and development expense for the quarter ending 2013-09-30 was $594.00K, a 70.27% decline year-over-year.
- CORNERSTONE THERAPEUTICS INC research and development expense for the quarter ending 2013-06-30 was $615.00K, a 10.35% decline year-over-year.
- CORNERSTONE THERAPEUTICS INC research and development expense for the quarter ending 2013-03-31 was $827.00K, a 20.86% decline year-over-year.
- CORNERSTONE THERAPEUTICS INC research and development expense for the quarter ending 2012-12-31 was $544.00K, a 115.87% increase year-over-year.
- CORNERSTONE THERAPEUTICS INC research and development expense for fiscal 2012 was $4.27M, a 163.12% increase from fiscal 2011.
- CORNERSTONE THERAPEUTICS INC research and development expense for fiscal 2011 was $1.62M, a 63.81% decline from fiscal 2010.
- CORNERSTONE THERAPEUTICS INC research and development expense for fiscal 2010 was $4.49M, a 24.39% increase from fiscal 2009.
- CORNERSTONE THERAPEUTICS INC research and development expense for fiscal 2009 was $3.61M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2013-09-30 | $594.00K 10-Q · filed 2013-11-07 | $1.21M derived: sum of 2 quarters · filed 2013-11-07 | $2.04M 10-Q · filed 2013-11-07 | $2.58M derived: sum of 4 quarters · filed 2013-11-07 |
| 2013-06-30 | $615.00K 10-Q · filed 2013-08-06 | $1.44M 10-Q · filed 2013-08-06 | $1.99M derived: sum of 3 quarters · filed 2013-08-06 | $3.98M derived: sum of 4 quarters · filed 2013-11-07 |
| 2013-03-31 | $827.00K 10-Q · filed 2013-05-09 | $1.37M derived: sum of 2 quarters · filed 2013-05-09 | $3.37M derived: sum of 3 quarters · filed 2013-11-07 | $4.05M derived: sum of 4 quarters · filed 2013-11-07 |
| 2012-12-31 | $544.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $2.54M derived: sum of 2 quarters · filed 2013-11-07 | $3.23M derived: sum of 3 quarters · filed 2013-11-07 | $4.27M 10-K · filed 2013-03-14 |
| 2012-09-30 | $2.00M 10-Q · filed 2012-11-08 | $2.68M derived: sum of 2 quarters · filed 2013-11-07 | $3.73M 10-Q · filed 2013-11-07 | $3.98M derived: sum of 4 quarters · filed 2013-11-07 |
| 2012-06-30 | $686.00K 10-Q · filed 2013-08-06 | $1.73M 10-Q · filed 2013-08-06 | $1.98M derived: sum of 3 quarters · filed 2013-08-06 | $2.18M derived: sum of 4 quarters · filed 2013-08-06 |
| 2012-03-31 | $1.04M 10-Q · filed 2013-05-09 | $1.30M derived: sum of 2 quarters · filed 2013-05-09 | $1.50M derived: sum of 3 quarters · filed 2013-05-09 | $2.11M derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $451.00K derived: sum of 2 quarters · filed 2013-03-14 | $1.06M derived: sum of 3 quarters · filed 2013-03-14 | $1.62M 10-K · filed 2013-03-14 |
| 2011-09-30 | $199.00K 10-Q · filed 2012-11-08 | $813.00K derived: sum of 2 quarters · filed 2012-11-08 | $1.37M 10-Q · filed 2012-11-08 | $2.11M derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-06-30 | $614.00K 10-Q · filed 2012-08-09 | $1.17M 10-Q · filed 2012-08-09 | $1.91M derived: sum of 3 quarters · filed 2013-03-14 | $2.96M derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-03-31 | $559.00K 10-Q · filed 2012-05-15 | $1.30M derived: sum of 2 quarters · filed 2013-03-14 | $2.35M derived: sum of 3 quarters · filed 2013-03-14 | $4.14M derived: sum of 4 quarters · filed 2013-03-14 |
| 2010-12-31 | $740.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $1.79M derived: sum of 2 quarters · filed 2013-03-14 | $3.58M derived: sum of 3 quarters · filed 2013-03-14 | $4.49M 10-K · filed 2013-03-14 |
| 2010-09-30 | $1.05M 10-Q · filed 2011-11-03 | $2.84M derived: sum of 2 quarters · filed 2011-11-03 | $3.75M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $1.79M 10-Q · filed 2011-08-04 | $2.70M 10-Q · filed 2011-08-04 | ||
| 2009-12-31 | $3.61M 10-K · filed 2012-03-06 |